There are many visions of the laboratory of the future. What they all have in common is that software and processes play a major role. With Labfolder, Labforward develops and distributes an electronic lab book, and with the networking solution Laboperator it creates the prerequisite for modern laboratory processes.

A new study made people with type 2 diabetes take part in a diet-assisted weight loss trial. The results showed differences across a wide range of potential biomarkers of metabolic health one year later.

Researchers have for the first time come up with a new DNA drug that can prevent blood clots without any side effects. The treatment has proved successful on mice and has the potential to go into human trials in a few years.

Researchers have used insects as a study model to understand the evolution of its brain functions and behaviors. In the future, this study may help researchers to understand the evolution of brain functions and behaviors in human beings.

Google Cloud’s Tensor Processing Units will be used by Bayer to speed up its in-silico research and development. The move will help the company to accelerate and scale its quantum chemistry calculations.

A study has revealed that patients who have been smoking in the short or medium term did as well as non-smokers if they quit smoking after undergoing a percutaneous coronary intervention. No improvements were seen in long term smokers.

Corona has presented the laboratory industry with major challenges. In a video report, exhibitors at Medica 2021 describe their solutions to this.

Researchers have developed an engineered tissue which represents a simplified cerebral cortex by 3D printing human stem cells. The method has the potential to repair and treat brain injuries.

A study by the Massachusetts Institute of Technology (MIT) has revealed that the locus coeruleus in the brain produces neuromodulator noradrenaline which assists the brain to learn in the event of surprizing situations.

People who received at least one influenza vaccine were 40 percent less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UT Health Houston.